The continued expansion of biosimilars and complex biologics will further democratise access to cutting-edge treatments worldwide, while the rapid growth of CRDMOs will establish India as a preferred destination for high-value outsourcing in an era of supply-chain reconfiguration.'' Domestic pharma is scaling up R&D, particularly for advanced biologics, GLs, antibody-drug conjugate, cell and gene therapies, and pivoting from simple to complex generics, according to Srikanth Mahadevan, director, Deloitte India.Further, "private equity interest will remain a dominant theme for healthcare providers, particularly hospitals, medical services and digital health
To this day, researchers are still trying to determine why IBS arises in some individuals
Composition of Ozempic, Wegovy, and Rybelsus U.S
New Ingredient: Endophytol Lets start with endophytol, a new trademarked ingredient derived from dandelion extract: Its a very nice anti-inflammatory, Lynch says, noting that reports of skin irritation from the original CEF are what inspired the company to look into anti-inflammatory ingredients that might pair well with the existing mix